SectorBiological Technology
Established Date--
Listing Date13/02/2020
ExchangeNASDAQ Stock Exchange
Full-time Employees534
Fiscal Year Ends31/12
Security TypeCommon stock
Office address700 Saginaw Drive, Redwood City, California 94063
Business
IntroductionRevolution Medicines, Inc., founded in October 2014, is a Delaware corporation. The company is a clinical-stage precision oncology company focused on developing targeted therapies to inhibit cutting-edge targets in RAS addictive cancer. The company has advanced structure-based drug discovery capabilities based on deep knowledge of chemical biology and cancer pharmacology and innovative proprietary technologies to create small molecules suitable for unconventional binding sites. The company's understanding of cancer's genetic drivers and adaptive resistance mechanisms, coupled with strong drug discovery and pharmacochemistry capabilities, has guided the establishment of a deep pipeline for key signaling nodes in the RAS pathway and related pathways.
